Albemarle（1ALB）株式概要アルベマール・コーポレーションは世界中にエネルギー貯蔵ソリューションを提供している。 詳細1ALB ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長4/6過去の実績0/6財務の健全性4/6配当金3/6報酬当社が推定した公正価値より49.6%で取引されている 収益は年間38.77%増加すると予測されています リスク分析Italian市場と比較して、過去 3 か月間の株価の変動が非常に大きい過去3か月間に大規模なインサイダー売却が発生 すべてのリスクチェックを見る1ALB Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€158.1080.6% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-1b9b2016201920222025202620282031Revenue US$7.6bEarnings US$710.7mAdvancedSet Fair ValueView all narrativesAlbemarle Corporation 競合他社SOLSymbol: BIT:SOLMarket cap: €5.4bBuzziSymbol: BIT:BZUMarket cap: €8.0bGanfeng Lithium GroupSymbol: SZSE:002460Market cap: CN¥155.5bDuPont de NemoursSymbol: NYSE:DDMarket cap: US$20.7b価格と性能株価の高値、安値、推移の概要Albemarle過去の株価現在の株価US$158.1052週高値US$186.0552週安値US$49.54ベータ1.361ヶ月の変化-0.63%3ヶ月変化12.24%1年変化202.01%3年間の変化n/a5年間の変化n/aIPOからの変化214.88%最新ニュースReported Earnings • May 11First quarter 2026 earnings released: EPS: US$2.35 (vs US$0.003 loss in 1Q 2025)First quarter 2026 results: EPS: US$2.35 (up from US$0.003 loss in 1Q 2025). Revenue: US$1.43b (up 33% from 1Q 2025). Net income: US$277.4m (up US$277.7m from 1Q 2025). Profit margin: 19% (up from 0% in 1Q 2025). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe.お知らせ • May 07Albemarle Corporation announces Quarterly dividend, payable on July 01, 2026Albemarle Corporation announced Quarterly dividend of USD 0.4050 per share payable on July 01, 2026, ex-date on June 12, 2026 and record date on June 12, 2026.お知らせ • Apr 07Albemarle Corporation to Report Q1, 2026 Results on May 06, 2026Albemarle Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 06, 2026お知らせ • Mar 25Albemarle Corporation Announces Director James O’Brien Will Not Stand for Re-Election, Effective May 5, 2026Albemarle Corporation announced James O’Brien, director will not stand for reelection. James O’Brien's directorship will end effective at the Annual Meeting to be held on May 5, 2026 pursuant to attained the age of 72 in 2026, and, accordingly, is not nominated for re-election at this annual meeting.お知らせ • Mar 12Albemarle Corporation, Annual General Meeting, May 05, 2026Albemarle Corporation, Annual General Meeting, May 05, 2026. Location: 4250 congress street north carolina 28209, charlotte, United Statesお知らせ • Mar 03+ 1 more updateKPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB).KPS Capital Partners, LP entered into a Stock Purchase Agreement to acquire Ketjen Corporation from Albemarle Corporation (NYSE:ALB) for $800 million on October 25, 2025. Under the terms of the Stock Purchase Agreement, Albemarle Corporation will sell 51% of the common stock of Ketjen (Purchased Shares) to KPS Capital Partners and contribute remaining 49% of common stock of Ketjen to Holdco, that was organized by and is affiliated with KPS Capital Partners LP. At the closing of the sale, contribution and other transactions contemplated by the Stock Purchase Agreement (collectively, the “Transaction”), Albemarle will receive an estimated $536 million in cash and will own common units of Holdco (the “Rollover Equity”). Under the Stock Purchase Agreement, the purchase price for the Purchased Shares is $800.0 million, less the value ascribed to the Contributed Shares pursuant to the terms and conditions of the Stock Purchase Agreement, and is further subject to adjustment for closing cash, indebtedness, net working capital and transaction expenses. Albemarle and KPS, through affiliates, will own approximately 49% and 51% of Ketjen at close, respectively, with KPS having a majority of the Board of Directors and operational control of Ketjen. The debt financing has been provided by Barclays, Jefferies, BNP Paribas and Santander. The termination fee of $32.5 million has to be paid by KPS Capital Partners, LP to Albemarle Corporation, if the closing has not occurred by April 30, 2026. The transactions is expected to be completed in the first half of 2026, with both subject to customary closing conditions and regulatory approvals, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), as well as approvals from competition and foreign investment authorities from certain non-U.S. jurisdictions and certain other governmental authorities. Goldman Sachs & Co. LLC acted as financial advisor and K&L Gates LLP acted as legal advisor for Albemarle Corporation. Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor and Raymond James Financial, Inc. acted as financial advisor for KPS Capital Partners, LP. Roel Fluit, Michel van Agt, Guido Koop, and Vincent van der Lans of Loyens & Loeff acted as legal advisor to KPS Capital Partners. KPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB) on March 2, 2026. Albemarle will retain reamining 49% stake in Ketjen.最新情報をもっと見るRecent updatesReported Earnings • May 11First quarter 2026 earnings released: EPS: US$2.35 (vs US$0.003 loss in 1Q 2025)First quarter 2026 results: EPS: US$2.35 (up from US$0.003 loss in 1Q 2025). Revenue: US$1.43b (up 33% from 1Q 2025). Net income: US$277.4m (up US$277.7m from 1Q 2025). Profit margin: 19% (up from 0% in 1Q 2025). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe.お知らせ • May 07Albemarle Corporation announces Quarterly dividend, payable on July 01, 2026Albemarle Corporation announced Quarterly dividend of USD 0.4050 per share payable on July 01, 2026, ex-date on June 12, 2026 and record date on June 12, 2026.お知らせ • Apr 07Albemarle Corporation to Report Q1, 2026 Results on May 06, 2026Albemarle Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 06, 2026お知らせ • Mar 25Albemarle Corporation Announces Director James O’Brien Will Not Stand for Re-Election, Effective May 5, 2026Albemarle Corporation announced James O’Brien, director will not stand for reelection. James O’Brien's directorship will end effective at the Annual Meeting to be held on May 5, 2026 pursuant to attained the age of 72 in 2026, and, accordingly, is not nominated for re-election at this annual meeting.お知らせ • Mar 12Albemarle Corporation, Annual General Meeting, May 05, 2026Albemarle Corporation, Annual General Meeting, May 05, 2026. Location: 4250 congress street north carolina 28209, charlotte, United Statesお知らせ • Mar 03+ 1 more updateKPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB).KPS Capital Partners, LP entered into a Stock Purchase Agreement to acquire Ketjen Corporation from Albemarle Corporation (NYSE:ALB) for $800 million on October 25, 2025. Under the terms of the Stock Purchase Agreement, Albemarle Corporation will sell 51% of the common stock of Ketjen (Purchased Shares) to KPS Capital Partners and contribute remaining 49% of common stock of Ketjen to Holdco, that was organized by and is affiliated with KPS Capital Partners LP. At the closing of the sale, contribution and other transactions contemplated by the Stock Purchase Agreement (collectively, the “Transaction”), Albemarle will receive an estimated $536 million in cash and will own common units of Holdco (the “Rollover Equity”). Under the Stock Purchase Agreement, the purchase price for the Purchased Shares is $800.0 million, less the value ascribed to the Contributed Shares pursuant to the terms and conditions of the Stock Purchase Agreement, and is further subject to adjustment for closing cash, indebtedness, net working capital and transaction expenses. Albemarle and KPS, through affiliates, will own approximately 49% and 51% of Ketjen at close, respectively, with KPS having a majority of the Board of Directors and operational control of Ketjen. The debt financing has been provided by Barclays, Jefferies, BNP Paribas and Santander. The termination fee of $32.5 million has to be paid by KPS Capital Partners, LP to Albemarle Corporation, if the closing has not occurred by April 30, 2026. The transactions is expected to be completed in the first half of 2026, with both subject to customary closing conditions and regulatory approvals, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), as well as approvals from competition and foreign investment authorities from certain non-U.S. jurisdictions and certain other governmental authorities. Goldman Sachs & Co. LLC acted as financial advisor and K&L Gates LLP acted as legal advisor for Albemarle Corporation. Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor and Raymond James Financial, Inc. acted as financial advisor for KPS Capital Partners, LP. Roel Fluit, Michel van Agt, Guido Koop, and Vincent van der Lans of Loyens & Loeff acted as legal advisor to KPS Capital Partners. KPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB) on March 2, 2026. Albemarle will retain reamining 49% stake in Ketjen.お知らせ • Feb 27Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on April 1, 2026The Board of Directors of Albemarle Corporation announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2026, to shareholders of record at the close of business as of March 13, 2026.お知らせ • Feb 12+ 2 more updatesAlbemarle Corporation Provides Earnings Guidance for 2026Albemarle Corporation provided earnings guidance for 2026. For the period the company expects the Net sales of $5.7 billion to $6.0 billion. Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025.お知らせ • Jan 14Albemarle Corporation to Report Q4, 2025 Results on Feb 11, 2026Albemarle Corporation announced that they will report Q4, 2025 results After-Market on Feb 11, 2026お知らせ • Dec 13Albemarle Corporation Announces Resignation of Dean L. Seavers as Director, Effective December 12, 2025Albemarle Corporation announced that Dean L. Seavers tendered his resignation from the Board of Directors and all committees on which he serves, effective December 12, 2025.Upcoming Dividend • Dec 04Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 11 December 2025. Payment date: 02 January 2026. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 1.3%. Lower than top quartile of Italian dividend payers (4.9%). Lower than average of industry peers (2.9%).Reported Earnings • Nov 06Third quarter 2025 earnings released: US$1.72 loss per share (vs US$9.45 loss in 3Q 2024)Third quarter 2025 results: US$1.72 loss per share (improved from US$9.45 loss in 3Q 2024). Revenue: US$1.31b (down 3.5% from 3Q 2024). Net loss: US$202.4m (loss narrowed 82% from 3Q 2024). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy.お知らせ • Nov 06+ 1 more updateAlbemarle Corporation Announces Goodwill Impairment Charges for the Third Quarter Ended September 30, 2025Albemarle Corporation announced Goodwill impairment charges for the third quarter ended September 30, 2025. For the period, the company reported Goodwill impairment charges of $181,070,000.Declared Dividend • Oct 31Dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 11th December 2025 Payment date: 2nd January 2026 Dividend yield will be 1.4%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.4% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.お知らせ • Oct 28Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on January 2, 2026The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable January 2, 2026, to shareholders of record at the close of business as of December 12, 2025.お知らせ • Sep 26Albemarle Corporation to Report Q3, 2025 Results on Nov 05, 2025Albemarle Corporation announced that they will report Q3, 2025 results After-Market on Nov 05, 2025お知らせ • Aug 12Albemarle Announces Executive Changes, Effective August 11, 2025Albemarle Corporation announced changes to its organizational structure to further align the company for agility and efficiency. These enhancements are designed to accelerate the company's market-led enterprise strategy and focus on operational excellence. Effective as of August 11, 2025: Mark Mummert will lead an integrated function of resources, manufacturing, capital and supply chain as chief operations officer continuing to report to Kent Masters, Albemarle's chairman and CEO. In this role, he will ensure optimization of Albemarle's world-class resources, including joint venture management, as well as global manufacturing. In addition, he will oversee capital projects and supply chain in a fully integrated operating model. With this change, Netha Johnson is leaving the company. Autumn Gagarinas will become Albemarle's chief people and workplace transformation officer, also reporting to Masters, to focus on talent and culture, as well as business process and technology optimization. Autumn has been serving as Albemarle's vice president of human resources for over two years and has over two decades of human resources experience. Melissa Anderson will continue to report to Masters and will lead Albemarle's enterprise strategy and growth, as well as research and technology as chief business transformation officer.Reported Earnings • Jul 31Second quarter 2025 earnings released: EPS: US$0.20 (vs US$1.96 loss in 2Q 2024)Second quarter 2025 results: EPS: US$0.20 (up from US$1.96 loss in 2Q 2024). Revenue: US$1.33b (down 7.0% from 2Q 2024). Net income: US$22.9m (up US$252.8m from 2Q 2024). Profit margin: 1.7% (up from net loss in 2Q 2024). Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy.お知らせ • Jul 31Albemarle Corporation Announces Executive Changeslbemarle Corporation announced that Ander Krupa has been promoted to executive vice president, general counsel, corporate secretary, and chief compliance officer. Krupa joined Albemarle in May 2017 as vice president, deputy general counsel, and assistant corporate secretary. He has served in leadership roles supporting Albemarle's global business units, commercial activities, and mergers and acquisitions. Krupa has more than 15 years of practice in the manufacturing industry and deep experience across Albemarle's businesses. Prior to Albemarle, Krupa served as assistant general counsel, governance, and securities for BWX Technologies Inc. and The Babcock & Wilcox Company. He was also an attorney with the international law firm of Greenberg Traurig LLP in the firm's corporate and securities practice group. Krupa received a bachelor's degree from the University of Georgia and earned his J.D. from Georgia State University College of Law. He is based in the company's Charlotte, N.C., headquarters and will report to Kent Masters as part of Albemarle's executive leadership team. Krupa assumes the role following the passing in April of Albemarle's former general counsel, corporate secretary, and chief compliance officer, Stacy Grant, at which time he was named as interim general counsel.お知らせ • Jul 23Albemarle Corporation Declares Quarterly Common Stock Dividend, Payable on October 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable October 1, 2025, to shareholders of record at the close of business as of September 12, 2025.お知らせ • Jun 19Albemarle Corporation to Report Q2, 2025 Results on Jul 30, 2025Albemarle Corporation announced that they will report Q2, 2025 results After-Market on Jul 30, 2025Buy Or Sell Opportunity • May 30Now 21% undervaluedThe stock has been flat over the last 90 days, currently trading at €49.88. The fair value is estimated to be €62.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.4% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 1.7% in a year. Earnings are forecast to grow by 100% in the next year.お知らせ • May 07Albemarle Announces Quarterly Common Stock Dividend, Payable on July 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025.Board Change • May 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 4 highly experienced directors. Independent Director Ralf Cramer was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.株主還元1ALBIT ChemicalsIT 市場7D-5.3%4.3%1.0%1Y202.0%35.3%18.6%株主還元を見る業界別リターン: 1ALB過去 1 年間で35.3 % の収益を上げたItalian Chemicals業界を上回りました。リターン対市場: 1ALB過去 1 年間で18.6 % の収益を上げたItalian市場を上回りました。価格変動Is 1ALB's price volatile compared to industry and market?1ALB volatility1ALB Average Weekly Movement8.5%Chemicals Industry Average Movement5.3%Market Average Movement5.1%10% most volatile stocks in IT Market8.3%10% least volatile stocks in IT Market3.1%安定した株価: 1ALBの株価は、 Italian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 1ALBの weekly volatility ( 9% ) は過去 1 年間安定していますが、依然としてItalianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト18877,800Jerry Masterswww.albemarle.comアルベマール・コーポレーションは世界中でエネルギー貯蔵ソリューションを提供している。3つのセグメントで事業を展開している：エネルギー貯蔵、スペシャリティーズ、ケッチェンである。エネルギー貯蔵部門は、家電製品や電気自動車に使用されるリチウム電池、送電網やソーラーパネルに使用される炭酸リチウム、水酸化リチウム、塩化リチウムなどのリチウム化合物、高性能グリース、家電製品や電子機器に使用される特殊ガラス、ステロイド化学やビタミン、様々なライフサイエンス分野での有機合成プロセス、製薬業界での中間体、反応性リチウム製品の取り扱いや使用などの技術サービス、リチウム含有副産物のリサイクルサービスなどを提供している。スペシャリティーズ部門は、エネルギー、モビリティ、コネクティビティ、火災安全化合物を含む健康など、様々な産業向けに臭素と高度に特殊化されたリチウムソリューションを提供する。臭素ベースのスペシャリティーケミカルズ製品としては、元素状臭素、臭化アルキル、無機臭化物、臭素化粉末活性炭、各種臭素ファインケミカルなどがある；ブチルリチウムや水素化アルミニウムリチウムなどのリチウム特殊化学品、化学・製薬業界向けのセシウム製品、エアバッグ用イニシエーターなどの火工品用途向けのジルコニウム、バリウム、チタン製品。ケッチェン部門は、異性化・アルキル化触媒を含む水素化分解触媒、流動接触分解触媒と添加剤、有機金属と硬化剤からなる性能触媒ソリューションなどのクリーン燃料技術を提供している。グリッド・ストレージ、自動車、航空宇宙、従来型エネルギー、エレクトロニクス、建設、農業、食品、製薬、医療機器業界にサービスを提供している。アルベマール・コーポレーションは1887年に設立され、ノースカロライナ州シャーロットに本社を置いている。もっと見るAlbemarle Corporation 基礎のまとめAlbemarle の収益と売上を時価総額と比較するとどうか。1ALB 基礎統計学時価総額€19.39b収益（TTM）-€343.89m売上高(TTM)€4.73b3.9xP/Sレシオ-53.2xPER（株価収益率1ALB は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計1ALB 損益計算書（TTM）収益US$5.49b売上原価US$4.48b売上総利益US$1.02bその他の費用US$1.42b収益-US$399.63m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-3.39グロス・マージン18.53%純利益率-7.27%有利子負債／自己資本比率17.6%1ALB の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.9%現在の配当利回り-48%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/15 23:34終値2026/05/15 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Albemarle Corporation 18 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。37 アナリスト機関William SeleskyArgus Research CompanyBenjamin KalloBairdAndres Castanos-MollorBerenberg34 その他のアナリストを表示
Reported Earnings • May 11First quarter 2026 earnings released: EPS: US$2.35 (vs US$0.003 loss in 1Q 2025)First quarter 2026 results: EPS: US$2.35 (up from US$0.003 loss in 1Q 2025). Revenue: US$1.43b (up 33% from 1Q 2025). Net income: US$277.4m (up US$277.7m from 1Q 2025). Profit margin: 19% (up from 0% in 1Q 2025). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe.
お知らせ • May 07Albemarle Corporation announces Quarterly dividend, payable on July 01, 2026Albemarle Corporation announced Quarterly dividend of USD 0.4050 per share payable on July 01, 2026, ex-date on June 12, 2026 and record date on June 12, 2026.
お知らせ • Apr 07Albemarle Corporation to Report Q1, 2026 Results on May 06, 2026Albemarle Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 06, 2026
お知らせ • Mar 25Albemarle Corporation Announces Director James O’Brien Will Not Stand for Re-Election, Effective May 5, 2026Albemarle Corporation announced James O’Brien, director will not stand for reelection. James O’Brien's directorship will end effective at the Annual Meeting to be held on May 5, 2026 pursuant to attained the age of 72 in 2026, and, accordingly, is not nominated for re-election at this annual meeting.
お知らせ • Mar 12Albemarle Corporation, Annual General Meeting, May 05, 2026Albemarle Corporation, Annual General Meeting, May 05, 2026. Location: 4250 congress street north carolina 28209, charlotte, United States
お知らせ • Mar 03+ 1 more updateKPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB).KPS Capital Partners, LP entered into a Stock Purchase Agreement to acquire Ketjen Corporation from Albemarle Corporation (NYSE:ALB) for $800 million on October 25, 2025. Under the terms of the Stock Purchase Agreement, Albemarle Corporation will sell 51% of the common stock of Ketjen (Purchased Shares) to KPS Capital Partners and contribute remaining 49% of common stock of Ketjen to Holdco, that was organized by and is affiliated with KPS Capital Partners LP. At the closing of the sale, contribution and other transactions contemplated by the Stock Purchase Agreement (collectively, the “Transaction”), Albemarle will receive an estimated $536 million in cash and will own common units of Holdco (the “Rollover Equity”). Under the Stock Purchase Agreement, the purchase price for the Purchased Shares is $800.0 million, less the value ascribed to the Contributed Shares pursuant to the terms and conditions of the Stock Purchase Agreement, and is further subject to adjustment for closing cash, indebtedness, net working capital and transaction expenses. Albemarle and KPS, through affiliates, will own approximately 49% and 51% of Ketjen at close, respectively, with KPS having a majority of the Board of Directors and operational control of Ketjen. The debt financing has been provided by Barclays, Jefferies, BNP Paribas and Santander. The termination fee of $32.5 million has to be paid by KPS Capital Partners, LP to Albemarle Corporation, if the closing has not occurred by April 30, 2026. The transactions is expected to be completed in the first half of 2026, with both subject to customary closing conditions and regulatory approvals, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), as well as approvals from competition and foreign investment authorities from certain non-U.S. jurisdictions and certain other governmental authorities. Goldman Sachs & Co. LLC acted as financial advisor and K&L Gates LLP acted as legal advisor for Albemarle Corporation. Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor and Raymond James Financial, Inc. acted as financial advisor for KPS Capital Partners, LP. Roel Fluit, Michel van Agt, Guido Koop, and Vincent van der Lans of Loyens & Loeff acted as legal advisor to KPS Capital Partners. KPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB) on March 2, 2026. Albemarle will retain reamining 49% stake in Ketjen.
Reported Earnings • May 11First quarter 2026 earnings released: EPS: US$2.35 (vs US$0.003 loss in 1Q 2025)First quarter 2026 results: EPS: US$2.35 (up from US$0.003 loss in 1Q 2025). Revenue: US$1.43b (up 33% from 1Q 2025). Net income: US$277.4m (up US$277.7m from 1Q 2025). Profit margin: 19% (up from 0% in 1Q 2025). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe.
お知らせ • May 07Albemarle Corporation announces Quarterly dividend, payable on July 01, 2026Albemarle Corporation announced Quarterly dividend of USD 0.4050 per share payable on July 01, 2026, ex-date on June 12, 2026 and record date on June 12, 2026.
お知らせ • Apr 07Albemarle Corporation to Report Q1, 2026 Results on May 06, 2026Albemarle Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 06, 2026
お知らせ • Mar 25Albemarle Corporation Announces Director James O’Brien Will Not Stand for Re-Election, Effective May 5, 2026Albemarle Corporation announced James O’Brien, director will not stand for reelection. James O’Brien's directorship will end effective at the Annual Meeting to be held on May 5, 2026 pursuant to attained the age of 72 in 2026, and, accordingly, is not nominated for re-election at this annual meeting.
お知らせ • Mar 12Albemarle Corporation, Annual General Meeting, May 05, 2026Albemarle Corporation, Annual General Meeting, May 05, 2026. Location: 4250 congress street north carolina 28209, charlotte, United States
お知らせ • Mar 03+ 1 more updateKPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB).KPS Capital Partners, LP entered into a Stock Purchase Agreement to acquire Ketjen Corporation from Albemarle Corporation (NYSE:ALB) for $800 million on October 25, 2025. Under the terms of the Stock Purchase Agreement, Albemarle Corporation will sell 51% of the common stock of Ketjen (Purchased Shares) to KPS Capital Partners and contribute remaining 49% of common stock of Ketjen to Holdco, that was organized by and is affiliated with KPS Capital Partners LP. At the closing of the sale, contribution and other transactions contemplated by the Stock Purchase Agreement (collectively, the “Transaction”), Albemarle will receive an estimated $536 million in cash and will own common units of Holdco (the “Rollover Equity”). Under the Stock Purchase Agreement, the purchase price for the Purchased Shares is $800.0 million, less the value ascribed to the Contributed Shares pursuant to the terms and conditions of the Stock Purchase Agreement, and is further subject to adjustment for closing cash, indebtedness, net working capital and transaction expenses. Albemarle and KPS, through affiliates, will own approximately 49% and 51% of Ketjen at close, respectively, with KPS having a majority of the Board of Directors and operational control of Ketjen. The debt financing has been provided by Barclays, Jefferies, BNP Paribas and Santander. The termination fee of $32.5 million has to be paid by KPS Capital Partners, LP to Albemarle Corporation, if the closing has not occurred by April 30, 2026. The transactions is expected to be completed in the first half of 2026, with both subject to customary closing conditions and regulatory approvals, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), as well as approvals from competition and foreign investment authorities from certain non-U.S. jurisdictions and certain other governmental authorities. Goldman Sachs & Co. LLC acted as financial advisor and K&L Gates LLP acted as legal advisor for Albemarle Corporation. Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor and Raymond James Financial, Inc. acted as financial advisor for KPS Capital Partners, LP. Roel Fluit, Michel van Agt, Guido Koop, and Vincent van der Lans of Loyens & Loeff acted as legal advisor to KPS Capital Partners. KPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB) on March 2, 2026. Albemarle will retain reamining 49% stake in Ketjen.
お知らせ • Feb 27Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on April 1, 2026The Board of Directors of Albemarle Corporation announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2026, to shareholders of record at the close of business as of March 13, 2026.
お知らせ • Feb 12+ 2 more updatesAlbemarle Corporation Provides Earnings Guidance for 2026Albemarle Corporation provided earnings guidance for 2026. For the period the company expects the Net sales of $5.7 billion to $6.0 billion. Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025.
お知らせ • Jan 14Albemarle Corporation to Report Q4, 2025 Results on Feb 11, 2026Albemarle Corporation announced that they will report Q4, 2025 results After-Market on Feb 11, 2026
お知らせ • Dec 13Albemarle Corporation Announces Resignation of Dean L. Seavers as Director, Effective December 12, 2025Albemarle Corporation announced that Dean L. Seavers tendered his resignation from the Board of Directors and all committees on which he serves, effective December 12, 2025.
Upcoming Dividend • Dec 04Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 11 December 2025. Payment date: 02 January 2026. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 1.3%. Lower than top quartile of Italian dividend payers (4.9%). Lower than average of industry peers (2.9%).
Reported Earnings • Nov 06Third quarter 2025 earnings released: US$1.72 loss per share (vs US$9.45 loss in 3Q 2024)Third quarter 2025 results: US$1.72 loss per share (improved from US$9.45 loss in 3Q 2024). Revenue: US$1.31b (down 3.5% from 3Q 2024). Net loss: US$202.4m (loss narrowed 82% from 3Q 2024). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy.
お知らせ • Nov 06+ 1 more updateAlbemarle Corporation Announces Goodwill Impairment Charges for the Third Quarter Ended September 30, 2025Albemarle Corporation announced Goodwill impairment charges for the third quarter ended September 30, 2025. For the period, the company reported Goodwill impairment charges of $181,070,000.
Declared Dividend • Oct 31Dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 11th December 2025 Payment date: 2nd January 2026 Dividend yield will be 1.4%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.4% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
お知らせ • Oct 28Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on January 2, 2026The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable January 2, 2026, to shareholders of record at the close of business as of December 12, 2025.
お知らせ • Sep 26Albemarle Corporation to Report Q3, 2025 Results on Nov 05, 2025Albemarle Corporation announced that they will report Q3, 2025 results After-Market on Nov 05, 2025
お知らせ • Aug 12Albemarle Announces Executive Changes, Effective August 11, 2025Albemarle Corporation announced changes to its organizational structure to further align the company for agility and efficiency. These enhancements are designed to accelerate the company's market-led enterprise strategy and focus on operational excellence. Effective as of August 11, 2025: Mark Mummert will lead an integrated function of resources, manufacturing, capital and supply chain as chief operations officer continuing to report to Kent Masters, Albemarle's chairman and CEO. In this role, he will ensure optimization of Albemarle's world-class resources, including joint venture management, as well as global manufacturing. In addition, he will oversee capital projects and supply chain in a fully integrated operating model. With this change, Netha Johnson is leaving the company. Autumn Gagarinas will become Albemarle's chief people and workplace transformation officer, also reporting to Masters, to focus on talent and culture, as well as business process and technology optimization. Autumn has been serving as Albemarle's vice president of human resources for over two years and has over two decades of human resources experience. Melissa Anderson will continue to report to Masters and will lead Albemarle's enterprise strategy and growth, as well as research and technology as chief business transformation officer.
Reported Earnings • Jul 31Second quarter 2025 earnings released: EPS: US$0.20 (vs US$1.96 loss in 2Q 2024)Second quarter 2025 results: EPS: US$0.20 (up from US$1.96 loss in 2Q 2024). Revenue: US$1.33b (down 7.0% from 2Q 2024). Net income: US$22.9m (up US$252.8m from 2Q 2024). Profit margin: 1.7% (up from net loss in 2Q 2024). Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy.
お知らせ • Jul 31Albemarle Corporation Announces Executive Changeslbemarle Corporation announced that Ander Krupa has been promoted to executive vice president, general counsel, corporate secretary, and chief compliance officer. Krupa joined Albemarle in May 2017 as vice president, deputy general counsel, and assistant corporate secretary. He has served in leadership roles supporting Albemarle's global business units, commercial activities, and mergers and acquisitions. Krupa has more than 15 years of practice in the manufacturing industry and deep experience across Albemarle's businesses. Prior to Albemarle, Krupa served as assistant general counsel, governance, and securities for BWX Technologies Inc. and The Babcock & Wilcox Company. He was also an attorney with the international law firm of Greenberg Traurig LLP in the firm's corporate and securities practice group. Krupa received a bachelor's degree from the University of Georgia and earned his J.D. from Georgia State University College of Law. He is based in the company's Charlotte, N.C., headquarters and will report to Kent Masters as part of Albemarle's executive leadership team. Krupa assumes the role following the passing in April of Albemarle's former general counsel, corporate secretary, and chief compliance officer, Stacy Grant, at which time he was named as interim general counsel.
お知らせ • Jul 23Albemarle Corporation Declares Quarterly Common Stock Dividend, Payable on October 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable October 1, 2025, to shareholders of record at the close of business as of September 12, 2025.
お知らせ • Jun 19Albemarle Corporation to Report Q2, 2025 Results on Jul 30, 2025Albemarle Corporation announced that they will report Q2, 2025 results After-Market on Jul 30, 2025
Buy Or Sell Opportunity • May 30Now 21% undervaluedThe stock has been flat over the last 90 days, currently trading at €49.88. The fair value is estimated to be €62.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.4% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 1.7% in a year. Earnings are forecast to grow by 100% in the next year.
お知らせ • May 07Albemarle Announces Quarterly Common Stock Dividend, Payable on July 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025.
Board Change • May 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 4 highly experienced directors. Independent Director Ralf Cramer was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
